Designing and screening of universal drug from neem (Azadirachta indica) and standard drug chemicals against influenza virus nucleoprotein
Aftab Ahmad, Muhammad Rizwan Javed, Abdul Qayyum Rao, Tayyab Husnain, Aftab Ahmad, Muhammad Rizwan Javed, Abdul Qayyum Rao, Tayyab Husnain
Abstract
Background: Different strains of influenza virus are affecting a large number of people worldwide. Many synthetic antiviral medicines are available for influenza virus in the market. But still there is a need for the development of universal drugs against these strains of influenza virus.
Methods: For this purpose conserved residues within the influenza virus nucleoprotein have been retrieved. The drugs, previously known to have antiviral properties, were screened to identify the best candidate universal drug against Influenza virus strains. Compounds from leaf extracts of neem, were also screened to identify the natural drugs without side effects.
Result: Molecular docking identified three potential compounds (Nimbaflavone, Rutin, and Hyperoside) having perfect binding with reported conserved residues (ASP302, SER50) of influenza virus nucleoprotein that is involved in the binding of drugs. Further analysis showed Hyperoside as a universal drug against various influenza strains. Some chemical drugs were also evaluated through screening against nucleoprotein. The results showed six drugs (OMS, CBX, LGH, Naproxen, BMS-883559, and BMS-885838) which were interacting with same conserved residues (ASP302, TYR52, SER50, GLY288, SER376, and ARG99) as were found in the case of neem phytochemicals. Hyperoside from neem leaf extract along with drugs LGH, Naproxen, BMS-885838, and BMS-883559 showed best interactions with conserved residues of nucleoprotein.
Conclusion: The compound Hyperoside from neem leaf extract along with drugs LGH, Naproxen, BMS-885838, and BMS-883559 showed best interactions with conserved residues of nucleoprotein. So these compounds have been identified for their potential against influenza strains to be utilized as a universal drug.
Keywords: Influenza virus; Molecular docking; Neem leaf extract; Nucleoprotein; Universal drug.
Figures
References
- Boyd M, Clezy K, Lindley R, Pearce R. Pandemic influenza: clinical issues. Med J Aust. 2006;185(10):S44.
- Kamal RP, Tosh C, Pattnaik B, Behera P, Nagarajan S, Gounalan S, et al. Analysis of the PB2 gene reveals that Indian H5N1 influenza virus belongs to a mixed-migratory bird sub-lineage possessing the amino acid lysine at position 627 of the PB2 protein. Arch Virol. 2007;152(9):1637–44. doi: 10.1007/s00705-007-1002-5.
- Stiver G. The treatment of influenza with antiviral drugs. Can Med Assoc J. 2003;168(1):49–57.
- Somvanshi P, Singh V, Seth P. Phylogenetic and computational proteome analysis of Influenza A virus subtype H5N1. Internet J Genomics Proteomics. 2008;3:2.
- Somvanshi P, Singh V, Seth P. Prediction of epitopes in hemagglutinin and neuraminidase proteins of influenza A virus H5N1 strain: A clue for diagnostic and vaccine development. OMICS. 2008;12(1):61–9. doi: 10.1089/omi.2007.0037.
- Smit M, Beynon KA, Murdochm DR, Jennings LC. Comparison of the NOW Influenza A & B, NOW Flu A, NOW Flu B, and Directigen Flu A+ B assays, and immunofluorescence with viral culture for the detection of influenza A and B viruses. Diagn Microbiol Infect Dis. 2007;57(1):67–70. doi: 10.1016/j.diagmicrobio.2006.11.003.
- Gerritz SW, Cianci C, Kim S, Pearce BC, Deminie C, Discotto L, et al. Inhibition of influenza virus replication via small molecules that induce the formation of higher-order nucleoprotein oligomers. Proc Natl Acad Sci. 2011;108(37):15366–71. doi: 10.1073/pnas.1107906108.
- Portela A, Digard P. The influenza virus nucleoprotein: a multifunctional RNA-binding protein pivotal to virus replication. J Gen Virol. 2002;83(4):723–34. doi: 10.1099/0022-1317-83-4-723.
- Kao RY, Yang D, Lau LS, Tsui WH, Hu L, Dai J, et al. Identification of influenza A nucleoprotein as an antiviral target. Nat Biotechnol. 2010;28(6):600–5. doi: 10.1038/nbt.1638.
- Jalil A, Ashfaq UA, Shahzadi S, Javed MR, Rasul I, Rehman SU, et al. Screening and design of anti-diabetic compounds sourced from the leaves of neem (Azadirachta indica) Bioinformation. 2013;9(20):1031. doi: 10.6026/97320630091031.
- Akanksha, Srivastava AK, Maurya R. Antihyperglycemic activity of compounds isolated from Indian medicinal plants. Indian J Exp Biol. 2010;48(3):294–8.
- Subapriya R, Nagini S. Medicinal properties of neem leaves: a review. Curr Med Chem Anti Cancer Agents. 2005;5(2):149–56. doi: 10.2174/1568011053174828.
- Koley K, Lal J. Pharmacological effects of Azadirachta indica (neem) leaf extract on the ECG and blood pressure of rat. Indian J Physiol Pharmacol. 1994;38(3):223–5.
- Khan M, Qasim M, Ashfaq UA, Idrees S, Shah M. Computer aided screening of Accacia nilotica phytochemicals against HCV NS3/4a. Bioinformation. 2013;9(14):710. doi: 10.6026/97320630009710.
- Cheng H, Wan J, Lin MI, Liu Y, Lu X, Liu J, et al. Design, Synthesis, and in Vitro Biological Evaluation of 1H-1, 2, 3-Triazole-4-carboxamide Derivatives as New Anti-influenza A Agents Targeting Virus Nucleoprotein. J Med Chem. 2012;55(5):2144–53. doi: 10.1021/jm2013503.
- Shen Z, Lou K, Wang W. New small-molecule drug design strategies for fighting resistant influenza A. Acta Pharm Sin B. 2015;5(5):419–30. doi: 10.1016/j.apsb.2015.07.006.
- Ahad A, Ahmad A, Din SU, Rao AQ, Shahid AA, Husnain T. In silico study for diversing the molecular pathway of pigment formation: an alternative to manual coloring in cotton fibers. Front Plant Sci. 2015;6:751. doi: 10.3389/fpls.2015.00751.
- Cianci C, Gerritz SW, Deminie C, Krystal M. Influenza nucleoprotein: promising target for antiviral chemotherapy. Antiviral Chem Chemother. 2013;23(3):77–91. doi: 10.3851/IMP2235.
- Orhan DD, Özçelik B, Özgen S, Ergun F. Antibacterial, antifungal, and antiviral activities of some flavonoids. Microbiol Res. 2010;165(6):496–504. doi: 10.1016/j.micres.2009.09.002.
- Wu LL, Yang XB, Huang ZM, Liu HZ, Wu GX. In vivo and in vitro antiviral activity of hyperoside extracted from Abelmoschus manihot (L) medik. Acta Pharmacol Sin. 2007;28:3.
- Gangar SC, Sandhir R, Koul A. Anti-clastogenic activity of Azadirachta indica against benzo (a) pyrene in murine forestomach tumorigenesis bioassay. Acta Pol Pharm. 2010;67:381–90.
- Lejal N, Tarus B, Bouguyon E, Chenavas S, Bertho N, Delmas B, et al. Structure-based discovery of the novel antiviral properties of naproxen against the nucleoprotein of influenza A virus. Antimicrob Agents Chemother. 2013;57(5):2231–42. doi: 10.1128/AAC.02335-12.
- Davis AM, Chabolla BJ, Newcomb LL. Emerging antiviral resistant strains of influenza A and the potential therapeutic targets within the viral ribonucleoprotein (vRNP) complex. Virol J. 2014;11(1):1. doi: 10.1186/1743-422X-11-167.
- Mullin AE, Dalton RM, Amorim MJ, Elton D, Digard P. Increased amounts of the influenza virus nucleoprotein do not promote higher levels of viral genome replication. J Gen Virol. 2004;85(12):3689–98. doi: 10.1099/vir.0.80518-0.
Source: PubMed